• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A critique of the regulation of data science in healthcare research in the European Union.对欧盟医疗保健研究中数据科学监管的批判。
BMC Med Ethics. 2017 Apr 8;18(1):27. doi: 10.1186/s12910-017-0184-y.
2
Genetic research and consent: On the crossroads of human and data research.遗传研究与同意:人类研究与数据研究的十字路口
Bioethics. 2019 Mar;33(3):347-356. doi: 10.1111/bioe.12475. Epub 2018 Aug 2.
3
Privacy compliance and enforcement on European healthgrids: an approach through ontology.欧洲健康网格中的隐私合规性和执行:一种通过本体论的方法。
Philos Trans A Math Phys Eng Sci. 2010 Sep 13;368(1926):4057-72. doi: 10.1098/rsta.2010.0169.
4
Informed consent, and an ethico-legal framework for paediatric observational research and biobanking: the experience of an Italian birth cohort study.知情同意以及儿科观察性研究和生物样本库的伦理法律框架:一项意大利出生队列研究的经验
Cell Tissue Bank. 2014 Dec;15(4):579-90. doi: 10.1007/s10561-014-9431-3. Epub 2014 Mar 5.
5
The use of personal data for medical research: how to deal with new European privacy standards.个人数据在医学研究中的使用:如何应对欧洲新的隐私标准。
Int J Biomed Comput. 1994 Feb;35 Suppl:87-95.
6
Biobanking, digital health and privacy: the choices of 1410 volunteers and neurological patients regarding limitations on use of data and biological samples, return of results and sharing.生物库、数字健康和隐私:1410 名志愿者和神经科患者对数据和生物样本使用限制、结果返还和共享的选择。
BMC Med Ethics. 2024 Sep 27;25(1):100. doi: 10.1186/s12910-024-01102-3.
7
A Literature Review on the GDPR, COVID-19 and the Ethical Considerations of Data Protection During a Time of Crisis.《关于 GDPR、COVID-19 以及危机时期数据保护伦理考量的文献综述》
Yearb Med Inform. 2021 Aug;30(1):226-232. doi: 10.1055/s-0041-1726512. Epub 2021 Sep 3.
8
Cancer registration, public health and the reform of the European data protection framework: Abandoning or improving European public health research?癌症登记、公共卫生与欧洲数据保护框架改革:摒弃还是改进欧洲公共卫生研究?
Eur J Cancer. 2015 Jun;51(9):1028-38. doi: 10.1016/j.ejca.2013.09.005. Epub 2013 Oct 10.
9
Health research and systems' governance are at risk: should the right to data protection override health?健康研究与系统治理面临风险:数据保护权是否应凌驾于健康之上?
J Med Ethics. 2014 Jul;40(7):488-92. doi: 10.1136/medethics-2013-101603.
10
Adjusting the focus: A public health ethics approach to data research.调整焦点:数据研究的公共卫生伦理方法。
Bioethics. 2019 Mar;33(3):357-366. doi: 10.1111/bioe.12551. Epub 2019 Jan 22.

引用本文的文献

1
High-reward, high-risk technologies? An ethical and legal account of AI development in healthcare.高回报、高风险技术?医疗保健领域人工智能开发的伦理与法律剖析
BMC Med Ethics. 2025 Jan 15;26(1):4. doi: 10.1186/s12910-024-01158-1.
2
Enabling Demonstrated Consent for Biobanking with Blockchain and Generative AI.通过区块链和生成式人工智能实现生物样本库的明确同意。
Am J Bioeth. 2025 Apr;25(4):96-111. doi: 10.1080/15265161.2024.2416117. Epub 2024 Nov 5.
3
Gaps in the Global Regulatory Frameworks for the Use of Artificial Intelligence (AI) in the Healthcare Services Sector and Key Recommendations.医疗服务领域使用人工智能(AI)的全球监管框架中的差距及关键建议。
Healthcare (Basel). 2024 Aug 30;12(17):1730. doi: 10.3390/healthcare12171730.
4
Advances in the Application of AI Robots in Critical Care: Scoping Review.人工智能机器人在重症监护中的应用进展:范围综述。
J Med Internet Res. 2024 May 27;26:e54095. doi: 10.2196/54095.
5
Research collaboration data platform ensuring general data protection.研究合作数据平台确保通用数据保护。
Sci Rep. 2024 May 24;14(1):11887. doi: 10.1038/s41598-024-61912-8.
6
Specific measures for data-intensive health research without consent: a systematic review of soft law instruments and academic literature.无同意数据密集型健康研究的具体措施:软性法律文书和学术文献的系统综述。
Eur J Hum Genet. 2024 Jan;32(1):21-30. doi: 10.1038/s41431-023-01471-0. Epub 2023 Oct 17.
7
What prevents us from reusing medical real-world data in research.是什么阻碍了我们在研究中重复使用医疗真实世界数据。
Sci Data. 2023 Jul 13;10(1):459. doi: 10.1038/s41597-023-02361-2.
8
The future regulation of artificial intelligence systems in healthcare services and medical research in the European Union.欧盟医疗服务与医学研究中人工智能系统的未来监管
Front Genet. 2022 Oct 4;13:927721. doi: 10.3389/fgene.2022.927721. eCollection 2022.
9
The social licence for data-intensive health research: towards co-creation, public value and trust.数据密集型健康研究的社会许可:走向共同创造、公共价值和信任。
BMC Med Ethics. 2021 Aug 10;22(1):110. doi: 10.1186/s12910-021-00677-5.
10
Understanding the Uptake of Big Data in Health Care: Protocol for a Multinational Mixed-Methods Study.了解医疗保健领域大数据的应用:一项跨国混合方法研究的方案
JMIR Res Protoc. 2020 Oct 22;9(10):e16779. doi: 10.2196/16779.

本文引用的文献

1
Sharing health-related data: a privacy test?分享健康相关数据:一项隐私测试?
NPJ Genom Med. 2016 Aug 17;1(1):160241-160246. doi: 10.1038/npjgenmed.2016.24.
2
Why patients shouldn't "own" their medical records.
Nat Biotechnol. 2016 Jun 9;34(6):586. doi: 10.1038/nbt.3552.
3
The president says patients should own their genetic data. He's wrong.
Nat Biotechnol. 2016 Jun 9;34(6):585-6. doi: 10.1038/nbt.3608.
4
RESEARCH ETHICS. Ethics review for international data-intensive research.研究伦理。国际数据密集型研究的伦理审查。
Science. 2016 Mar 25;351(6280):1399-400. doi: 10.1126/science.aad5269.
5
Unaddressed privacy risks in accredited health and wellness apps: a cross-sectional systematic assessment.经认证的健康与健身应用中未解决的隐私风险:一项横断面系统评估。
BMC Med. 2015 Sep 7;13:214. doi: 10.1186/s12916-015-0444-y.
6
Unpatients-why patients should own their medical data.非患者——为何患者应掌控自己的医疗数据。
Nat Biotechnol. 2015 Sep;33(9):921-4. doi: 10.1038/nbt.3340.
7
On moving targets and magic bullets: Can the UK lead the way with responsible data linkage for health research?关于移动目标与神奇子弹:英国能否在健康研究的负责任数据关联方面引领潮流?
Int J Med Inform. 2015 Nov;84(11):933-40. doi: 10.1016/j.ijmedinf.2015.08.011. Epub 2015 Aug 24.
8
Big data analytics in healthcare: promise and potential.医疗保健中的大数据分析:前景与潜力。
Health Inf Sci Syst. 2014 Feb 7;2:3. doi: 10.1186/2047-2501-2-3. eCollection 2014.
9
The social licence for research: why care.data ran into trouble.研究的社会许可:为何care.data陷入困境。
J Med Ethics. 2015 May;41(5):404-9. doi: 10.1136/medethics-2014-102374. Epub 2015 Jan 23.
10
Towards Principles-Based Approaches to Governance of Health-related Research using Personal Data.迈向基于原则的利用个人数据进行健康相关研究治理的方法。
Eur J Risk Regul. 2013 Jan 1;4(1):43-57. doi: 10.1017/s1867299x00002786.

对欧盟医疗保健研究中数据科学监管的批判。

A critique of the regulation of data science in healthcare research in the European Union.

作者信息

Rumbold John M M, Pierscionek Barbara K

机构信息

Faculty of Science, Engineering and Computing, Kingston University London, Penrhyn Road, Kingston upon Thames, KT1 2EE, UK.

School of Science and Technology School of Science and Technology, Nottingham Trent University, 50 Shakespeare Street, Nottingham, NG1 4FQ, UK.

出版信息

BMC Med Ethics. 2017 Apr 8;18(1):27. doi: 10.1186/s12910-017-0184-y.

DOI:10.1186/s12910-017-0184-y
PMID:28388916
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5385067/
Abstract

The EU offers a suitable milieu for the comparison and harmonisation of healthcare across different languages, cultures, and jurisdictions (albeit with a supranational legal framework), which could provide improvements in healthcare standards across the bloc. There are specific ethico-legal issues with the use of data in healthcare research that mandate a different approach from other forms of research. The use of healthcare data over a long period of time is similar to the use of tissue in biobanks. There is a low risk to subjects but it is impossible to gain specific informed consent given the future possibilities for research. Large amounts of data on a subject present a finite risk of re-identification. Consequently, there is a balancing act between this risk and retaining sufficient utility of the data. Anonymising methods need to take into account the circumstances of data sharing to enable an appropriate balance in all cases. There are ethical and policy advantages to exceeding the legal requirements and thereby securing the social licence for research. This process would require the examination and comparison of data protection laws across the trading bloc to produce an ethico-legal framework compatible with the requirements of all member states. Seven EU jurisdictions are given consideration in this critique.

摘要

欧盟提供了一个合适的环境,可用于比较和协调不同语言、文化和司法管辖区(尽管有一个超国家法律框架)的医疗保健,这可能会提高整个欧盟的医疗保健标准。医疗保健研究中数据的使用存在特定的伦理法律问题,这就要求采取与其他形式研究不同的方法。长期使用医疗保健数据类似于生物样本库中组织的使用。对受试者的风险较低,但鉴于未来的研究可能性,不可能获得具体的知情同意。关于一个受试者的大量数据存在重新识别的有限风险。因此,在这种风险与保留数据的足够效用之间需要进行权衡。匿名化方法需要考虑数据共享的情况,以便在所有情况下实现适当的平衡。超越法律要求从而获得研究的社会许可具有伦理和政策优势。这一过程将需要审查和比较贸易集团内的数据保护法律,以制定一个符合所有成员国要求的伦理法律框架。本评论考虑了七个欧盟司法管辖区。